"Conventional screening methods remain the most appropriate choice for first-line screening for most women in the general obstetric population," the committee wrote.
At the Clinical Genome Conference, commercial and academic test developers, researchers, and healthcare consultants discussed the state of genomic testing.
A proof-of-principle study suggests blood and saliva may contain markers for finding and following head and neck squamous cell carcinomas.
So far, results from the MSK-IMPACT test have been reported for more than 4,500 patients.
This is My will offer the test at its clinics in Leeds, Manchester, Liverpool, Hull, Coventry, Halifax, Durham, and London.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
The New York Times examines ethics and China's push to lead biomedical research.
At her blog, Sally Rockey dives into National Institutes of Health funding data.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.